The Latin America, Middle East and Africa Radiotherapy Market is expected to witness market growth of 8.2% CAGR during the forecast period (2022-2028).
From the original site of cancer, it might spread to other body parts. In spite of the fact that cancer cells cannot be seen on imaging tests like CT scans or MRIs, doctors frequently believe that a number of them may have already spread. In some instances, radiation therapy may be used to treat the region where cancer spreads most frequently in order to eradicate any cancer cells there before they develop into tumors. Because certain types of lung cancer frequently spread to the brain, patients with these cancers may receive radiation to the head even when there is no evidence of cancer there. This is done to assist in halting the spread of cancer to the skull even before it can.
Cancer symptoms are reduced and treated by radiation therapy. Radiation therapy can treat cancer and either cure it, stop it from coming back or limit its progress. Palliative treatments are those that are employed to relieve symptoms. To address pain and other issues brought on by the tumor, such as difficulty breathing or loss of bowel and bladder control, external beam radiation may cause tumors to shrink. Radiopharmaceuticals, which are substances used in systemic radiation therapy, can be used to relieve cancer pain that has progressed to the bone. Due to the increased efficiency of the treatment, it is widely being utilized all over the world.
When detected late, the prognosis for severe skin cancers like melanoma is dismal. People with darker skin types have significant disparities in the clinical and histological characteristics of melanoma as well as the course of the illness. According to the National Library of Medicines, the total incidence of melanoma across South Africa was 2.7 per 100 000, with 11 784 invasive melanomas recorded to the NCR. Males (51%) and people under the age of 60 (48%) were most frequently affected, and lower limb (36%) as well as trunk (27%) anatomical regions. Melanoma incidences were 23.2 and 0.5 per 100,000 in the white and black populations, respectively.
The Brazil market dominated the LAMEA Radiotherapy Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $132.4 million by 2028. The Argentina market is experiencing a CAGR of 8.8% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 7.9% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals & Clinics and Others. Based on Type, the market is segmented into External Beam Radiation Therapy, Internal Radiation Therapy and Systemic Radiation Therapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Siemens Healthineers AG, Accuray, Incorporated, Elekta AB, Eckert & Ziegler AG, Ion Beam Applications SA, iCAD Inc., Isoray Inc., Mevion Medical Systems, Inc., and Nordion Inc. (Sotera Health LLC).
From the original site of cancer, it might spread to other body parts. In spite of the fact that cancer cells cannot be seen on imaging tests like CT scans or MRIs, doctors frequently believe that a number of them may have already spread. In some instances, radiation therapy may be used to treat the region where cancer spreads most frequently in order to eradicate any cancer cells there before they develop into tumors. Because certain types of lung cancer frequently spread to the brain, patients with these cancers may receive radiation to the head even when there is no evidence of cancer there. This is done to assist in halting the spread of cancer to the skull even before it can.
Cancer symptoms are reduced and treated by radiation therapy. Radiation therapy can treat cancer and either cure it, stop it from coming back or limit its progress. Palliative treatments are those that are employed to relieve symptoms. To address pain and other issues brought on by the tumor, such as difficulty breathing or loss of bowel and bladder control, external beam radiation may cause tumors to shrink. Radiopharmaceuticals, which are substances used in systemic radiation therapy, can be used to relieve cancer pain that has progressed to the bone. Due to the increased efficiency of the treatment, it is widely being utilized all over the world.
When detected late, the prognosis for severe skin cancers like melanoma is dismal. People with darker skin types have significant disparities in the clinical and histological characteristics of melanoma as well as the course of the illness. According to the National Library of Medicines, the total incidence of melanoma across South Africa was 2.7 per 100 000, with 11 784 invasive melanomas recorded to the NCR. Males (51%) and people under the age of 60 (48%) were most frequently affected, and lower limb (36%) as well as trunk (27%) anatomical regions. Melanoma incidences were 23.2 and 0.5 per 100,000 in the white and black populations, respectively.
The Brazil market dominated the LAMEA Radiotherapy Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $132.4 million by 2028. The Argentina market is experiencing a CAGR of 8.8% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 7.9% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals & Clinics and Others. Based on Type, the market is segmented into External Beam Radiation Therapy, Internal Radiation Therapy and Systemic Radiation Therapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Siemens Healthineers AG, Accuray, Incorporated, Elekta AB, Eckert & Ziegler AG, Ion Beam Applications SA, iCAD Inc., Isoray Inc., Mevion Medical Systems, Inc., and Nordion Inc. (Sotera Health LLC).
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals & Clinics
- Others
By Type
- External Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiation Therapy
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Siemens Healthineers AG
- Accuray, Incorporated
- Elekta AB
- Eckert & Ziegler AG
- Ion Beam Applications SA
- iCAD Inc.
- Isoray Inc.
- Mevion Medical Systems, Inc.
- Nordion Inc. (Sotera Health LLC)
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Radiotherapy Market by End User
Chapter 5. LAMEA Radiotherapy Market by Type
Chapter 6. LAMEA Radiotherapy Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Siemens Healthineers AG
- Accuray, Incorporated
- Elekta AB
- Eckert & Ziegler AG
- Ion Beam Applications SA
- iCAD Inc.
- Isoray Inc.
- Mevion Medical Systems, Inc.
- Nordion Inc. (Sotera Health LLC)
Methodology
LOADING...
